Clinical Trial Update: Comparison Between Symbicort® and Prednisolone in COPD [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Symbicort with prednisolone in chronic obstructive pulmonary disease has completed, providing head-to-head results in COPD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Prednisolone (Prednisolone)
• Symbicort (budesonide/formoterol)

Snippet

Sponsor: AstraZeneca | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: COMPLETED